Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BBOT
BBOT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBOT News
Emerging Trends in Rare Disease Drug Development
3d ago
CNBC
BridgeBio Appoints New CEO and COO
Apr 22 2026
seekingalpha
BBOT Appoints New CEO and COO to Drive Growth
Apr 22 2026
Newsfilter
FDA Grants Fast Track Designation to BBO-11818 for Pancreatic Cancer
Apr 21 2026
NASDAQ.COM
BridgeBio Oncology Receives FDA Fast Track Designation for BBO-11818
Apr 20 2026
seekingalpha
BBOT Receives FDA Fast Track Designation for BBO-11818
Apr 20 2026
Newsfilter
BBO-11818: New KRAS Inhibitor Shows Promising Potential
Mar 06 2026
Newsfilter
BridgeBio Oncology Reports Q4 2025 Financial Results and R&D Updates
Mar 05 2026
seekingalpha
Latest Rating Changes on Wall Street
Feb 11 2026
CNBC
BridgeBio to Present Novel Therapeutics at 44th J.P. Morgan Healthcare Conference
Dec 16 2025
Globenewswire
BridgeBio Oncology to Present Pipeline Advances at 44th J.P. Morgan Healthcare Conference
Dec 16 2025
Newsfilter
BridgeBio Grants 53,060 Stock Options to New Employee as Inducement
Dec 11 2025
Globenewswire
BridgeBio Grants 53,060 Stock Options to New Employee as Inducement
Dec 11 2025
Newsfilter
BBOT's BBO-10203 Significantly Inhibits Tumor Activity in Preclinical Studies
Dec 10 2025
Globenewswire
BBOT's BBO-10203 Significantly Inhibits Tumor Activity in Preclinical Studies
Dec 10 2025
Newsfilter
Major Analyst Recommendations for Friday: Nvidia, Apple, CoreWeave, Broadcom, Alphabet, Netflix, and Others
Dec 05 2025
CNBC
Show More News
